United Kingdom

Activist investor secures meeting with GSK chairman and the backing of corporate raider

An activist investor pushing for a shake-up at GlaxoSmithKline has secured a meeting with the drugs giant's chairman – and the backing of corporate raider Elliott. 

Sources said Bluebell Capital Partners is due to meet Sir Jonathan Symonds within weeks.

Bluebell wants GSK chief executive Emma Walmsley to reapply for her job ahead of the separation of the group's biopharma and consumer businesses next year. 

It also wants a 'proactive' approach to considering a sale rather than a demerger of the consumer arm. 

Its demands echo those of Elliott Management, which took a multi-billion pound stake this year. Bluebell's stake in GSK is €10 million.

Marco Taricco, Bluebell's chief investment officer, said: 'Our message is consistent with Elliott's but we are not working in concert.'

Football news:

Carlo Ancelotti: Clasico will exist without Messi, Ronaldo and Ramos. We don't know yet what Fati and Vinicius will achieve
Zlatan has the first goal in his career. He also has an assist and a goal with Bologna
Ronaldo on Sulscher's criticism: Manchester United players must take responsibility for themselves. All in the same boat
Sulscher about Manchester United: We are not happy that we lost points. But Ronaldo has only been with us for a month, Sancho for two. We will add
Muller on Kimmich: As a teammate, I am for vaccination, if I think about others, as a friend, I can make his decision
Chelsea won't buy Saul out. He spent 45 minutes in the Premier League
Pioli on 4-2 with Bologna: Milan made a mistake, deciding that the game was over at 2-0, but found the strength to win